RFP - Supply of immune checkpoint inhibitors for the treatment of locally advanced and metastatic non-small cell lung ca
Pharmaceutical Management Agency awarded NZ$140M to ROCHE PRODUCTS (NEW ZEALAND) LIMITED for Pharmaceuticals in March 2023 — one of 97 awards this buyer has made, above its typical award size.
Buying agency
Pharmaceutical Management AgencyWinning supplier
ROCHE PRODUCTS (NEW ZEALAND) LIMITEDContract description
RFP - Supply of immune checkpoint inhibitors for the treatment of locally advanced and metastatic non-small cell lung cancer
Related awards · Pharmaceutical Management Agency
97 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- 22162611Eli Lilly and Company (NZ) LimitedNZ$100M08 Apr 2021 Pharmaceuticals
- 20433854Seqirus NZNZ$37.5M10 Oct 2019 Pharmaceuticals
- 20264267USL MedicalNZ$22.0M07 Sep 2022 Healthcare
Other wins · ROCHE PRODUCTS (NEW ZEALAND) LIMITED
2 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- 31321250Health New Zealand (Te Whatu Ora)Not disclosed29 Oct 2024 Pharmaceuticals
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Pharmaceutical Management Agency and ROCHE PRODUCTS (NEW ZEALAND) LIMITED — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back